Ultragenyx Pharmaceutical Inc.
NASDAQ-GS: RARE
.USD
-2.98 (12.68%)↓ today
Price at Feb 13, 4:00:01 PM EST • Market Closed
Loading...
Details
Valuations
Market Cap
Market Cap
Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles
1.98B
PEG Ratio
PEG Ratio
Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles
-0.11
Trailing P/E Ratio
Trailing P/E Ratio
Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles
-3.26
Forward P/E Ratio
Forward P/E Ratio
Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles
-5.79
Financial Performance
Revenue (TTM)
630.60M
Operating Cash Flow (TTM)
-445.67M
Net Profit Margin (TTM)
Net Profit Margin (TTM)
Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"
Related Articles
-91.95%
Diluted EPS (TTM)
Diluted EPS (TTM)
Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles
-5.93
Cash
Total Cash (MRQ)
425.25M
Operating Free Cash Flow (TTM)
-445.67M
Levered Free Cash Flow (TTM)
-195.18M
Total Cash per Share (MRQ)
4.42
Advanced Valuations
Enterprise Value
2.74B
Enterprise Value to EBITDA
-5.40
Price-to-Sales (TTM)
Price-to-Sales (TTM)
Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles
3.65
Price-to-Book (MRQ)
251.37
Balance Sheet
Total Debt (MRQ)
863.11M
Debt to Equity (MRQ)
5.34K
Current Ratio (MRQ)
1.89
Book Value per Share (MRQ)
0.10
Detailed Financials
Revenue Growth (MRQ)
14.70%
Earnings Growth (YOY)
14.65%
Return on Equity (TTM)
-313.43%
Gross Profit Margin
Gross Profit Margin
Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"
Related Articles
82.50%
Share Information
Shares Outstanding
96.44M
Shares Float
92.90M
Beta
0.16
52-Week Range
18.41 - 46.27
Trading & Ownership
Institutional Ownership
104.78%
Insider Ownership
3.13%
Short Interest
9.76%
Average 90-Day Volume
2.96M
Dividends
Payout Ratio
0.00%
Forward Dividend Yield
0.00%
Ex. Dividend Date
Unknown
Dividend Date
Unknown
Indicators
Founder-Operated
No
Founder-operated companies generally perform better.
CEO
Emil D. Kakkis
Founders
Dr. Emil D. Kakkis M.D., Ph.D.
Industry Safety Score
1/5
Biotechnology
Net Profitability Score
1/5
As compared to these industry peers.
Loading...
Indicators
Founder-Operated
No
Founder-operated companies generally perform better.
CEO
Emil D. Kakkis
Founders
Dr. Emil D. Kakkis M.D., Ph.D.
Industry Safety Score
1/5
Biotechnology
Net Profitability Score
1/5
As compared to these industry peers.
Details
Valuations
Market Cap
Market Cap
Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles
1.98B
PEG Ratio
PEG Ratio
Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles
-0.11
Trailing P/E Ratio
Trailing P/E Ratio
Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles
-3.26
Forward P/E Ratio
Forward P/E Ratio
Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles
-5.79
Financial Performance
Revenue (TTM)
630.60M
Operating Cash Flow (TTM)
-445.67M
Net Profit Margin (TTM)
Net Profit Margin (TTM)
Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"
Related Articles
-91.95%
Diluted EPS (TTM)
Diluted EPS (TTM)
Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles
-5.93
Cash
Total Cash (MRQ)
425.25M
Operating Free Cash Flow (TTM)
-445.67M
Levered Free Cash Flow (TTM)
-195.18M
Total Cash per Share (MRQ)
4.42
Advanced Valuations
Enterprise Value
2.74B
Enterprise Value to EBITDA
-5.40
Price-to-Sales (TTM)
Price-to-Sales (TTM)
Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles
3.65
Price-to-Book (MRQ)
251.37
Balance Sheet
Total Debt (MRQ)
863.11M
Debt to Equity (MRQ)
5.34K
Current Ratio (MRQ)
1.89
Book Value per Share (MRQ)
0.10
Detailed Financials
Revenue Growth (MRQ)
14.70%
Earnings Growth (YOY)
14.65%
Return on Equity (TTM)
-313.43%
Gross Profit Margin
Gross Profit Margin
Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"
Related Articles
82.50%
Share Information
Shares Outstanding
96.44M
Shares Float
92.90M
Beta
0.16
52-Week Range
18.41 - 46.27
Trading & Ownership
Institutional Ownership
104.78%
Insider Ownership
3.13%
Short Interest
9.76%
Average 90-Day Volume
2.96M
Dividends
Payout Ratio
0.00%
Forward Dividend Yield
0.00%
Ex. Dividend Date
Unknown
Dividend Date
Unknown